CCL2 and diabetic macular edema: Levels of extracellular MCP-1 have been shown to be significantly elevated in patients with diabetic macular edema, and levels of MCP-1 could be significantly reduced after treatment, in association with a reduction in overall central macular thickness (Owen and Hartnett, 2013).